Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cacciola

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Journal of Psychotherapy Practice and Research|June 16, 2012
Factors in Outcomes of Short-Term Dynamic Psychotherapy for Chronic vs. Nonchronic Major DepressionL Luborsky, L Diguer, J Cacciola, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2000
Synthesis and activity studies of conformationally restricted alpha-ketoamide factor Xa inhibitorsJ Cacciola, J M Fevig, P F Stouten, et al.
The Journal of Nervous and Mental Disease|July 1, 1985
New data from the Addiction Severity Index. Reliability and validity in three centersA T McLellan, L Luborsky, J Cacciola, et al.
Drug and Alcohol Dependence|April 2, 1999
Methadone-maintenance outcomes for Hispanic and African-American men and womenF D Mulvaney, L S Brown, A I Alterman, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Preparation of meta-amidino-N,N-disubstituted anilines as potent inhibitors of coagulation factor XaJ M Fevig, J Cacciola, R S Alexander, et al.
Archives of General Psychiatry|September 1, 1991
Independent assessment of manic and depressive symptoms by self-rating. Scale characteristics and implications for the study of maniaM S Bauer, P Crits-Christoph, W A Ball, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Rational design of boropeptide thrombin inhibitors: beta, beta-dialkyl-phenethylglycine P2 analogs of DuP 714 with greater selectivity over complement factor I and an improved safety profileJ M Fevig, J Buriak, J Cacciola, et al.
Journal of Medicinal Chemistry|February 15, 2001
Discovery of 1-[3-(aminomethyl)phenyl]-N-3-fluoro-2'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor XaD J Pinto, M J Orwat, S Wang, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Journal of Psychotherapy Practice and Research|June 16, 2012
Factors in Outcomes of Short-Term Dynamic Psychotherapy for Chronic vs. Nonchronic Major DepressionL Luborsky, L Diguer, J Cacciola, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2000
Synthesis and activity studies of conformationally restricted alpha-ketoamide factor Xa inhibitorsJ Cacciola, J M Fevig, P F Stouten, et al.
The Journal of Nervous and Mental Disease|July 1, 1985
New data from the Addiction Severity Index. Reliability and validity in three centersA T McLellan, L Luborsky, J Cacciola, et al.
Drug and Alcohol Dependence|April 2, 1999
Methadone-maintenance outcomes for Hispanic and African-American men and womenF D Mulvaney, L S Brown, A I Alterman, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Preparation of meta-amidino-N,N-disubstituted anilines as potent inhibitors of coagulation factor XaJ M Fevig, J Cacciola, R S Alexander, et al.
Archives of General Psychiatry|September 1, 1991
Independent assessment of manic and depressive symptoms by self-rating. Scale characteristics and implications for the study of maniaM S Bauer, P Crits-Christoph, W A Ball, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Rational design of boropeptide thrombin inhibitors: beta, beta-dialkyl-phenethylglycine P2 analogs of DuP 714 with greater selectivity over complement factor I and an improved safety profileJ M Fevig, J Buriak, J Cacciola, et al.
Journal of Medicinal Chemistry|February 15, 2001
Discovery of 1-[3-(aminomethyl)phenyl]-N-3-fluoro-2'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor XaD J Pinto, M J Orwat, S Wang, et al.
Pageof 2